Capricor Therapeutics to Present at Upcoming Scientific and Medical Conferences
Capricor Therapeutics, Inc. (CAPR)
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
capricor.com/investors
Company Research
Source: GlobeNewswire
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at various upcoming scientific and medical conferences. Event:American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting (Baltimore, MD)Date:May 7–11, 2024Format:Oral Presentation/Abstract: Exosome-mediated intracellular delivery of arginase-1: a potential application for the treatment of Arginase-1 Deficiency Event:Parent Project Muscular Dystrophy (PPMD) Cardiac Workshop III (Baltimore, MD)Date:May 9–10, 2024Format:Panel: Industry perspectives on cardiac monitoring in DMD clinical trials Event:International Society of Extracellular Vesicles (ISEV) 2024 Meeting (Melbourne, Australia)Date:May 9–12, 2024Format:Abstract: Targeted cargo delivery to mouse lower limb by exosomes carrying a muscle targeting moiety with in
Show less
Read more
Impact Snapshot
Event Time:
CAPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAPR alerts
High impacting Capricor Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CAPR
News
- Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) had its price target raised by analysts at LADENBURG THALM/SH SH from $24.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.MarketBeat
- Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.MarketBeat
CAPR
Earnings
- 5/13/24 - Miss
CAPR
Sec Filings
- 5/15/24 - Form 8-K
- 5/15/24 - Form 8-K
- 5/14/24 - Form 10-Q
- CAPR's page on the SEC website